ImageneBio, Inc. (IMA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $39.86M
Last updated: Nov 17, 2026 at 4:10 PM ET
ImageneBio, Inc. (IMA) Stock Chart
ImageneBio (IMA) has a latest price of $3.90 on Nov 17, 2026, 50.6% below its 52-week high of $7.89. Its price fell 52.2% over the past 12 months. The month-end price fell 96.8% over the 5 years through Oct 2026, a compound annual decline of 49.8%.
Price Chart
From Mar 2021 to Oct 2026, its highest month-end close was $339.14 in Mar 2021 and its lowest $4.10 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IMA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 31.5%, and over 6 months it fell 25.7%. The month-end price fell 91.5% over the 3 years through Oct 2026, a compound annual decline of 56.1%.
| Period | Change |
|---|---|
| 1 month | -2.5% |
| 3 months | -31.5% |
| 6 months | -25.7% |
| 12 months | -52.2% |
| 12 months, with dividends | -52.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -91.5% | -56.1% |
| 5 years | -96.8% | -49.8% |
Price by Year
Its best calendar year was 2024, when the price fell 16.8%, and its weakest was 2022, when it fell 78.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.10 | -40.6% |
| 2025 | $6.90 | -65.0% |
| 2024 | $19.69 | -16.8% |
| 2023 | $23.65 | -25.9% |
| 2022 | $31.93 | -78.8% |
Trading Range
The price is 10.0% below its 50-day average of $4.33 and 28.3% below its 200-day average of $5.44.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.90 | |
| 52-week high | $7.89 | -50.6% |
| 52-week low | $3.13 | +24.6% |
| 50-day average | $4.33 | -10.0% |
| 200-day average | $5.44 | -28.3% |
Price Risk
Over 3 years, its largest fall from a peak was 88.2%.
| Measure | Value |
|---|---|
| 1-year beta | 0.64 |
| Largest fall, 1 year | -58.4% |
| Largest fall, 3 years | -88.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IMA
What is IMA's 1-year price change?
ImageneBio's price fell 52.2% over the past 12 months. With dividends included, the 12-month total return was -52.2%.
What is IMA's 5-year price change?
ImageneBio's month-end price fell 96.8% over the 5 years through Oct 2026, a compound annual decline of 49.8%. These figures leave out dividends.
What is IMA's 52-week high and low?
ImageneBio's 52-week high is $7.89 and its 52-week low is $3.13. Its latest price of $3.90 on Nov 17, 2026 is 50.6% below the high.
What is IMA's beta?
ImageneBio's 1-year beta against the S&P 500 is 0.64, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 58.4%.
Is the IMA chart free?
Yes. Advanced Charting for IMA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IMA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors